Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 41,198 shares at $13.12 ($541K) on 2024-02-28, disclosed to the SEC on 2024-03-01.
Scheduled sale ($541k) by Executive VP, European Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.12 | 20,599 | $270K | 50.0% |
| 2 | $13.12 | 20,599 | $270K | 50.0% |
| Total | $13.12 avg | 41,198 | $541K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |